Annual Report — For the Year Ended 31 December 2019
Imagion Biosystems Limited has released its audited financial statements for 2019. View the Annual Report for the year ended 31 December 2019.
Bob Proulx Discusses the Opportunity for MagSense™ Imaging
Watch Imagion CEO Bob Proulx discuss the opportunity for MagSense™ Imaging on Switzer's CEO Masterclass: https://youtu.be/kpJ0Lpwdk38 Today’s imaging…
Rights Trading Commences
Imagion Biosystems Limited (ASX:IBX) is pleased to confirm that the rights the subject of the Company’s Renounceable Rights Issue announced on Wednesday, 25…
Change to Board of Directors — Director Resignation
Imagion Biosystems Limited has accepted the resignation of non-executive director Bronwyn Le Grice. Ms Le Grice's resignation is effective March 31st, 2020.…
Renounceable Rights Issue Prospectus
Imagion Biosystems Limited has released the Renounceable Rights Issue Prospectus: For a renounceable pro rata offer of 204,512,879 Shares at an issue price of…
Appendix 3B — Renounceable Rights Issue
Imagion Biosystems Limited has released Appendix 3B — Renounceable Rights Issue. Read Appendix 3B.
Pro-Rata Renounceable Rights Issue
Imagion Biosystems Limited has released "Pro-Rata Renounceable Rights Issue". Highlight of this issue include: Funds to complete the manufacture of…
Trading Halt
The securities of Imagion Biosystems Limited ('IBX') will be placed in trading halt at the request of IBX, pending it releasing an announcement. Unless ASX…
Change of Registered Address
Imagion Biosystems Limited wishes to advise that its Australian registered office address has changed with immediate effect to: c/o K&L Gates, Level 25,…
Investor Presentation — Imagion Biosystems MagSense™ Technology
President and CEO Bob Proulx today addressed investors at the Switzer Small and Microcap Investor Day in Sydney Australia. He discussed recent milestones,…